DOCSLIB.ORG

Immunogenetics & TB Treatment Strategies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immunogenetics & TB Treatment Strategies Immunogenetics & TB Treatment Strategies: Hope or Hype? Thomas Hawn, MD-PhD University of Washington Division of Allergy & Infectious Diseases Advancing HDT for TB NIH Workshop April 15, 2014 Outline 1. The Challenge 2. Mendelian Lessons 3. Complex Lessons 4. Lessons from other infections 5. Future: Therapeutic Implications 1. Massive Genetic Variation: Random or Regulatory? Genomic DNA ATGGACTGGA ... ATGGTCTGGA ... Single Nucleotide Polymorphism • Human Genome: 3 billion bases • SNPs ~0.1% Which SNPs: alter cell function? affect susceptibility to TB? 2. Redundancy: Signaling Nightmares 47 Chemokines 23 Type I Cytokines 17 Type II Cytokines 9 TNF Family Aderem & Smith 2004 Why do TB and BCG affect individuals differently? Pathogen Virulence factors Aims Host Host 1. Identify Variation External Factors: Genetics 2. Pathogenesis Exposure Immunosuppression 3. New Rx Complex Inheritance: TB I. Twin Studies # Tb cases/100 co-twins Monozyogotic 31.4 Dizyogotic 14.9 The Prophit Survey by Barbara Simonds. Comstock et al Am Rev Resp Dis 117: 621-624 (1978) Genetics & Immunodeficiency Alcais et al JCI 2009 Casanova Ann Rev Gen 2013 Primary Major Gene “Common” Inheritance Mendelian Complex Complexity Monogenic Polygenic Penetrance High Moderate Low for single allele Frequency Rare Common Age Onset Early Variable Features Severe Mild Type Mutations Polymorphisms Genetics & Mycobacteria Rare Mendelian Inheritance Mostly BCG, NTM infections & Salmonella Tb TLR Mor DC IL-12 Mutations IKK IKK T cell IL-12p40 IL-12R IL-12R IFNR1 IFNR2 IFNR IFN STAT1 Abs STAT1 JL Casanova & L Abel Annu Rev Immunol 20: MICROBIAL 581-620 (2002) KILLING Specificity & TLR Mendelian Diseases Extracellular Pathogen CD14 TLRs 1/2/4/5/6 MyD88,TIRAP, TRIF, TRAM IRAK1, IRAK2, IRAK4, IRAK-M TLR3 Unc93b TRIF IKK, IKK, IKK (NEMO) TRAF3, TBK1 I-B Susceptible to: NF-B IRF3 & 7 Nucleus Extracellualar HSV Bacteria NF-kB IRF3& 7 TNF, IL12, IL6 IFN, Mendelian Resistance HIV & CCR532 & Maraviroc Malaria & Duffy Factor (DARC) Plasmodia RBC Duffy Factor Receptor required for P. vivax entry Sickle Cell Anemia pts protected against malaria Complex Inheritance: TB IIA. Genome-wide linkage scans TB Disease 15q & Xq, Gambia: Bellamy et al. PNAS 97: 8005-9 (2000) 2q35, Canada: Greenwood et al Am J Hum Gen 67: 405-16 (2000) 8q12-13, Morocco: Baghdadi et al JEM 203: 1679 (2006) TB Infection 11p14, 5p15 South Africa: Cobat et al JEM 2009 2q21, 5p13 Uganda: Stein, Boom et al Plos1 2008 IIB. GWAS 18q11.2 Thye et al Nat Gen 2010; 11p3 Thye Nat Gen 2012 BCG Pathogenesis Primary Droplet Lung 1° Infection Progressive Dz Inhalation Alveolar M Spread to LN Latent 90% Bacillemia No Infection 10% 80% Reactivate Lung Apex “Rich Foci” Disseminated Pulmonary Dz Meninges & Brain Miliary “Reactivation” Lymph Node Bone (Pott’s Disease) R. Hewlett NEJM (2004) Genitourinary Why Failure? Paucity of phenotypic discrimination TB infection vs TB Disease Site of TB Disease Pulmonary vs meningeal vs other Primary vs reactivation Children vs adults Treatment response Zhang et al NEJM 2009 N=3254 cases 5955 controls TLR1 T1805G & Leprosy A. Misch & Hawn PLoS NTD 2008 1805G & leprosy RR B. Johnson et al J Immunol 2007 1805G & leprosy: OR 0.48 (0.29-0.80) C. Wong et al PlosPathogens 2010 Genotyped 50,000 SNPs in 2,092 genes 2 major associations: 1. HLA-DRB1/DQA1 2. TLR1 T1805G (I602S) & leprosy Combined analysis of 3 case-control studies 1805G: OR 0.37 P=1.7 x 10-9 Human TLR1/6 Deficiency epidemiology Signal High frequency ↓ ↓ lipopeptide defect TLR2 ethnic variation signaling TLR1/6 SNPs Cellular phenotype Clinical PAM3:TT/GT PAM3:GG phenotypes 3000 2500 2000 1500 1000 [IL-6 pg/ml] 500 0 0 100 200 300 400 [PAM3 ng/ml] ?leprosy RR, sepsis, malaria HCV & Innate Immunity Extracellular HCV GWAS IL28B (IFNL3) SNPs HCV PAMPs TLR3 & HCV self cure PKR, RIG-I, MAVS TRIF HCV Rx TRAF3, TBK1 response IRF3 & 7 IRF3 & 7 IRF3& 7 IFN,, Kills HCV Complex Inheritance: TB IV. TB Candidate Gene Association Studies Adaptive Immune Response MHC Class II Cytokines/Chemokines/Inflammatory Pathways IL-1Ra/IL-1 IL-8 LTA4H MCP-1 IFN- Innate Immunity and Macrophage Function NRAMP1 (SLC11a1) VDR P2X7 DC-SIGN SP110 (IPR-1) MBP TLR1, 2,8 TIRAP NOD2 TOLLIP LTA4H, TNF, & TB Meningitis LTA4H SNP rs17525495 associated with higher promoter activity, higher mRNA levels, higher CSF WBC, and improved survival after dexamethasone Rx Tobin et al Cell 2010, Tobin et al Cell 2012 TOLLIP rs5743899 & susceptibility to TB? Extracellular IL-1R MTB Autophagy TLRs MyD88 MyD88 IRAK1 IRAK1 LC3 Phagosome p62 Auto- NF-B TOLLIP phagosome Nucleus Auto-phagolysosome with MTB Killing NF-kB TNF, IL12, IL6 NO, ROI, anti-microbial peptides Is TOLLIIP-deficiency Associated with Adult TB? N Cord Blood Controls (N) 762 Adults with Pulmonary TB (N) 385 Adults with Meningeal TB (N) 307 HIV-infected (%) 0 Age (Mean) 38 Jeremy Farrar Sarah Dunstan Sex (% female) 37 Ho Chi Minh City, Vietnam The Hospital for Tropical Diseases Pham Ngoc Thach Hospital for Tuberculosis Oxford University Clinical Research Unit TOLLIP rs5743899 Associated with risk of both pulmonary & meningeal TB Case Control & TOLLIP Control Case (frequency) (frequency) Geno Dom 00 01 11 00 01 11 P P OR TOLLIP rs5743854 0.416 0.495 0.089 0.535 0.351 0.114 0.001 0.002 0.619 rs5743890 0.939 0.061 0.000 0.974 0.026 0.000 0.037 0.037 0.405 rs5743899 0.316 0.504 0.180 0.394 0.459 0.147 0.092 0.033 0.711 rs5743915 0.340 0.470 0.190 0.250 0.518 0.232 0.039 0.013 1.545 rs7481967 0.308 0.527 0.166 0.403 0.437 0.160 0.026 0.009 0.659 Cape Town Collaborators: W. Hanekom, M. Hatherill, T. Scriba, M. Shey, M. Musvosi, & SATVI Team Human TOLLIP Deficiency Rs5743899 mimics knockdown C 20 * 15 10 6 4 TOLLIP mRNA 2 0 Javeed Shah A/A A/G G/G rs5743899 Associated with susceptibility to adult TB in Vietnam Genotypic analysis P<1x 10-7 TOLLIP: Negative Regulator of TLR1/2/4/6-mediated IL-6 A Experiment 20000 none * 1. shRNA Knockdown 15000 control in monocytes 10000 TOLLIP 2. Stimulate with TLR 5000 * * ligands or MTB x 3000 24h [IL-6 pg/ml] 2000 1000 3. ELISA 0 Med PAM2PAM3 LPS MTb TOLLIP: Negative Regulator of TLR1/2/4/6-mediated IL-6 ExperimentA D 20000 1. Isolate PBMC,none n=64 * 10000 ** 15000 control 8000 healthy10000 volunteersTOLLIP 2. Stimulate5000 with TLR 6000 * 4000 3000 * ligands or MTB x pg/ml] [IL-6 [IL-6 pg/ml] [IL-6 2000 2000 24h1000 0 0 A/A A/G G/G A/A A/G G/G A/A A/G G/G 3. ELISAMed PAM2PAM3 LPS MTb LPS PAM3 MTB rs5743899 N= 35 21 7 shRNA knockdown of TOLLIP in human IL-6 secretion in human monocytes monocytes Stratified by rs5743899 TOLLIP inhibits rapamycin- induced autophagy Tollip KD 1. siRNA Knockdown in THP1s Neg7 Cont 2. Rapamycin induced autophagy x 4h (55%) 6 3. P62 or LC3 western blot 5 Media Rapamycin Rapa Media Rapa 4 Media Rapamycin P62 3 2 Fold p62, by Actin Fold Change LC3 B-Actin 1 p62 0 Control TOLLIP Auto-phagosome formation ↑LC3II P62:Actin 0.81 0.28 0.55 1.81 ↓p62 Data: Javeed Shah, Stephen Hawn TOLLIP Deficiency Summary TLR2 TLR2 TLR4 TOLLIP SNP TLR1 TLR6 1. ↓ mRNA 2. Altered Monocyte TOLLIP Cytokines Regulates TLR1/2/4/6 3. TB Susceptibility Adult TB Vietnam Pediatric TB SA IL-6 IL-10 TNF TOLLIP Knockdown 4. ↑MTB Replication 5. ↓ autophagy Genetics & TB HDTs Genetic Finding Progress: Pathogeneis or HDT 1. Mendelian Mycobacteria: IL12/IFN Others: HSV, Pyogenic, Candida HIV: CCR5 & Maraviroc 2. GWAS TB: Positive findings, but no genes yet Leprosy: NOD2/RIPK2, HLA, TLR1 HCV & IL28B 3. Candidate Gene Abacavir hypersensitivity & HLAB5701 TB examples: LTA4H & dexamethasone Rx TOLLIP & autophagy Genetics & TB HDTs What is next? 1. Target IL-12/IFN- axis? 2. Fine map GWAS and genome- wide linkage findings 3. Study more discrete phenotypes 4. Examine Genetics of TB Rx Response Acknowledgements: Collaborators SATVI Vietnam CWRU W. Hanekom S Dunstan H Boom T. Scriba J Farrar C Stein M. Hatherill NTT Thuong M. Musvosvi NTB Yen M. Shey G Thwaites Uganda G. Hussey H Mayanja-Kizza B. Abel Seattle BioMed M Joloba A. Keyser A. Aderem B. Kagina D. Sherman L. Lerumo NJ, UMDNJ M. De Kock G. Kaplan A. Hawkridge B. Pleixoto J. Hughes Acknowledgements: UW Lab Rick Wells Chetan Seshadri Tom Dave Horne Javeed Shah Bill Berrington Matt Arentz Ann Misch Jay Vary Randi Simmons, Kelsey Nebeck, Monica Campo, Glenna Peterson Funding: NIH, Burroughs-Welcome Fund, Dana Fnd.
Load more

Recommended publications
  • RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
    RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Human Toll-Like Receptor Signaling Pathway Cat. no. 330231 PAHS-018ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Human Toll-Like Receptor (TLR) Signaling Pathway RT² Profiler PCR Array profiles the expression of 84 genes central to TLR-mediated signal transduction and innate immunity. The TLR family of pattern recognition receptors (PRRs) detects a wide range of bacteria, viruses, fungi and parasites via pathogen-associated molecular patterns (PAMPs). Each receptor binds to specific ligands, initiates a tailored innate immune response to the specific class of pathogen, and activates the adaptive immune response.
    [Show full text]
  • TLR Signaling Pathways
    Seminars in Immunology 16 (2004) 3–9 TLR signaling pathways Kiyoshi Takeda, Shizuo Akira∗ Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, and ERATO, Japan Science and Technology Corporation, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan Abstract Toll-like receptors (TLRs) have been established to play an essential role in the activation of innate immunity by recognizing spe- cific patterns of microbial components. TLR signaling pathways arise from intracytoplasmic TIR domains, which are conserved among all TLRs. Recent accumulating evidence has demonstrated that TIR domain-containing adaptors, such as MyD88, TIRAP, and TRIF, modulate TLR signaling pathways. MyD88 is essential for the induction of inflammatory cytokines triggered by all TLRs. TIRAP is specifically involved in the MyD88-dependent pathway via TLR2 and TLR4, whereas TRIF is implicated in the TLR3- and TLR4-mediated MyD88-independent pathway. Thus, TIR domain-containing adaptors provide specificity of TLR signaling. © 2003 Elsevier Ltd. All rights reserved. Keywords: TLR; Innate immunity; Signal transduction; TIR domain 1. Introduction 2. Toll-like receptors Toll receptor was originally identified in Drosophila as an A mammalian homologue of Drosophila Toll receptor essential receptor for the establishment of the dorso-ventral (now termed TLR4) was shown to induce the expression pattern in developing embryos [1]. In 1996, Hoffmann and of genes involved in inflammatory responses [3]. In addi- colleagues demonstrated that Toll-mutant flies were highly tion, a mutation in the Tlr4 gene was identified in mouse susceptible to fungal infection [2]. This study made us strains that were hyporesponsive to lipopolysaccharide [4]. aware that the immune system, particularly the innate im- Since then, Toll receptors in mammals have been a major mune system, has a skilful means of detecting invasion by focus in the immunology field.
    [Show full text]
  • Innate Immunity and Inflammation of the Bovine Female Reproductive Tract
    REPRODUCTIONREVIEW Innate immunity and inflammation of the bovine female reproductive tract in health and disease I Martin Sheldon, James G Cronin, Gareth D Healey, Christoph Gabler1, Wolfgang Heuwieser2, Dominik Streyl3, John J Bromfield4, Akio Miyamoto5, Chrys Fergani6 and Hilary Dobson6 College of Medicine, Institute of Life Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK, 1Institute of Veterinary Biochemistry and 2Clinic of Animal Reproduction, Freie Universitaet Berlin, Berlin, Germany, 3Clinic for Ruminants with Ambulatory and Herd Health Services, Centre for Clinical Veterinary Medicine, Ludwig Maximilian University of Munich, Oberschleißheim, Germany, 4Department of Animal Sciences, University of Florida, Gainesville, Florida 32608, USA, 5Graduate School for Animal and Food Hygiene, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan and 6School of Veterinary Science, University of Liverpool, Leahurst, Neston CH64 7TE, UK Correspondence should be addressed to I M Sheldon; Email: [email protected] Abstract Mammalian reproductive physiology and the development of viviparity co-evolved with inflammation and immunity over millennia. Many inflammatory mediators contribute to paracrine and endocrine signalling, and the maintenance of tissue homeostasis in the female reproductive tract. However, inflammation is also a feature of microbial infections of the reproductive tract. Bacteria and viruses commonly cause endometritis, perturb ovarian follicle development and suppress the endocrine activity of the hypothalamus and pituitary in cattle. Innate immunity is an evolutionary ancient system that orchestrates host cell inflammatory responses aimed at eliminating pathogens and repairing damaged tissue. Pattern recognition receptors on host cells bind pathogen-associated molecular patterns and damage-associated molecular patterns, leading to the activation of intracellular MAPK and NFkB signalling pathways and the release of inflammatory mediators.
    [Show full text]
  • Inflammation in Innate and Adaptive Immune Mechanisms October 28 – 30, 2012 Hilton Grand Wailea Resort | Maui, Hawai’I Organizers: Tom Hamilton and Xiaoxia Li
    45th Annual Meeting of The Society for Leukocyte Biology InflammatIon In Innate and adaptIve Immune mechanIsms October 28 – 30, 2012 Hilton Grand Wailea Resort | Maui, Hawai’i Organizers: Tom Hamilton and Xiaoxia Li abstracts Journal of Leukocyte Biology, Supplement 2012 www.leukocytebiology.org 45th AnnuAl Meeting of the Society for leukocyte Biology inflAMMAtion in innAte And AdAptive iMMune MechAniSMS grAnd WAileA, MAui, hAWAi’i ~ octoBer 28-30, 2012 Thank you to the supporters of the 2012 SLB Meeting! Journal of Leukocyte Biology Supplement 2012 ABSTRACTS 1 2 Alcohol and Drugs of Abuse Interaction with HIV/AIDS: Chronic Alcohol Consumption Increases Mortality in Sepsis Systems Biology Approach in the SIV-Infected Macaque Benyam P. Yoseph, Zhe Liang, Elise Breed, Kevin McConnell, Patricia E. Molina David M. Guidot, Michael Koval, Craig M. Coopersmith Comprehensive Alcohol Research Center, Louisiana State Emory University School of Medicine University Health Sciences Center, NOLA Introduction: Excessive alcohol abuse is a problem of particular The two most commonly used and abused drugs are alcohol concern in the intensive care unit (ICU), as the rate of morbidity and the cannabinoids. Alcohol and drugs of abuse have been and mortality in all patients admitted to ICU is 2-4 times greater demonstrated to alter host response to human immunodeficiency than in non-alcoholics. Sepsis is the leading cause of death in ICU. (HIV) infection; by affecting progression of infection, tissue The purpose of this study was to examine the pathophysiology of injury, and time to death. Several factors can be involved in chronic alcohol abuse in sepsis. this, those pertaining to the host response, as well as those Methods: FVB/N mice were given liquid ethanol diet (20% w/v) or related to the ability of the virus to integrate itself into the host water for 12 weeks.
    [Show full text]
  • Immune Stress up Regulates TLR4 and Tollip Gene Expression in the Hypothalamus of Ewes
    Journal of Animal and Feed Sciences, Vol. 22, No. 1, 2013, 13–18 The Kielanowski Institute of Animal Physiology and Nutrition PAS Jabłonna Immune stress up regulates TLR4 and Tollip gene expression in the hypothalamus of ewes A.P. Herman1,3, A. Herman2, K. Haziak1, and D. Tomaszewska-Zaremba1 1 The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland 2 The Academy of Cosmetics and Health Care in Warsaw, 00-252 Warsaw, Poland KEY WORDS: ewe, hypothalamus, ABSTRACT. Bacterial endotoxin, LPS, is recognized by Toll-like receptor-4 lipopolysaccharide, Toll-like receptor-4, (TLR4) and induces a signaling cascade leading to synthesis of proinflamma- Toll-interacting protein tory cytokines and induction of sickness behavior in animals. Transduction of the TLR4 signal is controlled by a potent negative regulator—Toll-interacting protein. The presented study concerns the effect of intravenously injected LPS on the level of expression of TLR4 and Tollip genes in the hypothalamus of ewes. Endotoxin increased (P < 0.01) cortisol release and expression of TLR4 and Tollip genes in the preoptic area (1.87 ± 0.42 and 1.31 ± 0.15), Received 19 September 2012 anterior hypothalamus (1.77 ± 0.22 and 1.27 ± 0.13), medial basal hypothala- Revised 18 February 2013 mus (2.53 0.65 and 1.43 ± 0.15), and median eminence (2.93 ± 0.46 and Accepted 18 March 2013 1.73 ± 0.10), respectively, in comparison with non-treated animals. Our results show that immune stress increases TLR4 gene expression in the hypothala- 3 Corresponding author: mus.
    [Show full text]
  • Inflammation Fas Modulating Intestinal TLR-Mediated Through TLR4 And
    Intestinal Expression of Fas and Fas Ligand Is Upregulated by Bacterial Signaling through TLR4 and TLR5, with Activation of Fas Modulating Intestinal TLR-Mediated This information is current as Inflammation of September 24, 2021. Philana Fernandes, Charlotte O'Donnell, Caitriona Lyons, Jonathan Keane, Tim Regan, Stephen O'Brien, Padraic Fallon, Elizabeth Brint and Aileen Houston J Immunol 2014; 193:6103-6113; Prepublished online 5 Downloaded from November 2014; doi: 10.4049/jimmunol.1303083 http://www.jimmunol.org/content/193/12/6103 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2014/11/05/jimmunol.130308 Material 3.DCSupplemental References This article cites 43 articles, 20 of which you can access for free at: http://www.jimmunol.org/content/193/12/6103.full#ref-list-1 by guest on September 24, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD
    [Show full text]
  • TOLLIP Promotes Durable Alveolar Macrophage-Mediated Immunity During Mycobacterium Tuberculosis Infection by Resolving Cellular
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.24.263624; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 TOLLIP promotes durable alveolar macrophage-mediated immunity during Mycobacterium 2 tuberculosis infection by resolving cellular stress from lipids. 3 4 Sambasivan Venkatasubramanian1, Courtney Plumlee2, Kim Dill-McFarland1, Gemma L. 5 Pearson3, Sara B. Cohen2, Anne Lietzke3, Amanda Pacheco3, Robyn Pryor1, Scott A. 6 Soleimanpour3,4, Matthew Altman1, Kevin B. Urdahl2,5, Javeed A. Shah1,6*. 7 1 Department of Medicine, University of Washington, Seattle, WA. 8 2 Seattle Children’s Research Institute, Seattle, WA. 9 3 Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 10 4 VA Ann Arbor Healthcare System, Ann Arbor, MI. 11 5 Departments of Pediatrics and Immunology, University of Washington, Seattle, WA. 12 6 VA Puget Sound Healthcare System, Seattle, WA. * Correspondence: [email protected]; @ShahLab. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.24.263624; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 13 Summary 14 TOLLIP, a ubiquitin binding protein that controls multiple macrophage functions via 15 endoplasmic reticulum transport and autophagy, is associated with human tuberculosis (TB) 16 susceptibility and immune responses in genetic studies.
    [Show full text]
  • Product Data Sheet
    KAMIYA BIOMEDICAL COMPANY Rev. 091305 PRODUCT DATA SHEET Product: Toll Interacting Protein (TOLLIP/TOLIP) (IN) polyclonal Cat. No.: PC-599 (100 µµµg) Storage and Stability : Store at -20˚C. Aliquot to avoid repeat Background: freeze/thaw cycles. Toll-like receptors (TRLs) are evolutionarily conserved pattern recognition molecules Applications and Suggested Dilutions: resembling the toll proteins that mediate Western blot: use at 1 µg/mL antimicrobial responses in Drosophila. These Immunohistochemistry proteins recognize different microbial products during infection and serve as an important link The optimal dilution for a specific application between the innate and adaptive immune should be determined by the researcher. responses. The TLRs act through adaprot molecules to activate various kinases and Limitations: transcription factors so the organism can For in vitro research use only. Not for use in respond to potential infection. These adaptor diagnostics or in humans. molecules include TOLLIP, MyD88, and TRIF. TOLLIP associates directly with TLR2 and TLR4, Warranty: acting as an inhibitor to TLR activation. This No warranties, expressed or implied, are made negative regulation of TLR signaling may serve regarding the use of this product. KAMIYA to limit the production of pro-inflammatory BIOMEDICAL COMPANY is not liable for any mediators during infection and inflammation. damage, personal injury, or economic loss caused by this product. Molecular Weight: 30 kD kDa Species Reactivity: Human, Rat, and Mouse Host : Rabbit Isotype: IgG Positive Control: Rat brain lysate. Located in cytoplasm and phosphorylated by IRAK1 upon stimulation by IL-1 or microbial products. Immunogen: Rabbit polyclonal TOLLIP antibody was raised against a peptide corresponding to 16 amino acids near the center of human TOLLIP.
    [Show full text]
  • Lipopolysaccharide Signaling in Endothelial Cells
    Laboratory Investigation (2006) 86, 9–22 & 2006 USCAP, Inc All rights reserved 0023-6837/06 $30.00 www.laboratoryinvestigation.org Lipopolysaccharide signaling in endothelial cells Shauna M Dauphinee1,2 and Aly Karsan1,2,3,4 1Department of Medical Biophysics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 2Experimental Medicine Program, University of British Columbia, Vancouver, British Columbia, Canada; 3Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada and 4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Sepsis is the systemic immune response to severe bacterial infection. The innate immune recognition of bacterial and viral products is mediated by a family of transmembrane receptors known as Toll-like receptors (TLRs). In endothelial cells, exposure to lipopolysaccharide (LPS), a major cell wall constituent of Gram- negative bacteria, results in endothelial activation through a receptor complex consisting of TLR4, CD14 and MD2. Recruitment of the adaptor protein myeloid differentiation factor (MyD88) initiates an MyD88-dependent pathway that culminates in the early activation of nuclear factor-jB (NF-jB) and the mitogen-activated protein kinases. In parallel, a MyD88-independent pathway results in a late-phase activation of NF-jB. The outcome is the production of various proinflammatory mediators and ultimately cellular injury, leading to the various vascular sequelae of sepsis.
    [Show full text]
  • Cytokine Production by Suppressing Tollip Promotes TLR-Triggered
    Histone Lysine Methyltransferase Ezh1 Promotes TLR-Triggered Inflammatory Cytokine Production by Suppressing Tollip This information is current as Yiqi Liu, Qian Zhang, Yuanyuan Ding, Xia Li, Dezhi Zhao, of September 27, 2021. Kai Zhao, Zhenhong Guo and Xuetao Cao J Immunol published online 16 February 2015 http://www.jimmunol.org/content/early/2015/02/16/jimmun ol.1402087 Downloaded from Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on September 27, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published February 16, 2015, doi:10.4049/jimmunol.1402087 The Journal of Immunology Histone Lysine Methyltransferase Ezh1 Promotes TLR-Triggered Inflammatory Cytokine Production by Suppressing Tollip Yiqi Liu,*,†,1 Qian Zhang,†,1 Yuanyuan Ding,* Xia Li,* Dezhi Zhao,* Kai Zhao,† Zhenhong Guo,† and Xuetao Cao*,†,‡ Histone modifications play critical roles in the regulation of gene expression; however, their roles in the regulation of the innate response remain to be fully investigated.
    [Show full text]
  • Functional Expression of TLR5 of Different Vertebrate Species And
    www.nature.com/scientificreports OPEN Functional expression of TLR5 of diferent vertebrate species and diversifcation in intestinal Received: 4 December 2017 Accepted: 10 July 2018 pathogen recognition Published: xx xx xxxx Eugenia Faber1,2, Karsten Tedin3, Yvonne Speidel1,2, Melanie M. Brinkmann4 & Christine Josenhans 1,2,5 Toll-like receptor 5 (TLR5) is activated by bacterial fagellins and plays a crucial role in the frst-line defence against pathogenic bacteria and in immune homeostasis, and is highly conserved in vertebrate species. However, little comparative information is available on TLR5 functionality. In this study, we compared TLR5 activation using full-length and chimeric TLR5 of various vertebrate species (human, chicken, mouse, pig, cattle). Chimeric TLR5 receptors, consisting of human transmembrane and intracellular domains, linked to extracellular domains of animal origin, were generated and expressed. The comparison of chimeric TLR5s and their full-length counterparts revealed signifcant functional disparities. While porcine and chicken full-length TLR5s showed a strongly reduced functionality in human cells, all chimeric receptors were functional when challenged with TLR5 ligand Salmonella FliC. Using chimeric receptors as a tool allowed for the identifcation of ectodomain-dependent activation potential and partially host species-specifc diferences in response to various enteric bacterial strains and their purifed fagellins. We conclude that both the extra- and intracellular determinants of TLR5 receptors are crucial for compatibility with the species expression background and hence for proper receptor functionality. TLR5 receptors with a common intracellular domain provide a useful system to investigate bacteria- and host-specifc diferences in receptor activation. Toll-like receptor 5 (TLR5) is a crucial determinant of pathogen-host interaction and essential for immune home- ostasis1–4.
    [Show full text]
  • Tollip-Induced Down-Regulation of MARCH1
    Results in Immunology 3 (2013) 17–25 Contents lists available at ScienceDirect Results in Immunology j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / r i n i m ଝ Tollip-induced down-regulation of MARCH1 Marie-Claude Bourgeois-Daigneault a, Abdul Mohammad Pezeshki a, Tristan Galbas a, Mathieu Houde b, Martin Baril b, Klaus Fr uh¨ c, Abdelaziz Amrani d, Satoshi Ishido e, Daniel Lamarre b, Jacques Thibodeau a,* aLaboratoire d’Immunologie Mol ´eculaire, D ´epartement de Microbiologie et Immunologie, Universit ´e de Montr ´eal, QC, Canada bInstitut de recherche en immunologie et en canc ´erologie, IRIC, Universit ´e de Montr ´eal, QC, Canada cVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA dD ´epartement de P ´ediatrie, Service d ’Immunologie et d’Allergologie, Universit ´e de Sherbrooke, Sherbrooke, QC, Canada eLaboratory of Infectious Immunity, Yokohama Institute, Research Center for Allergy and Immunology, Japan a r t i c l e i n f o a b s t r a c t Article history: In addition to their classical antigen presenting functions, MHC class II molecules potentiate the TLR-triggered Received 29 January 2013 production of pro-inflammatory cytokines. Here, we have addressed the effect of Tollip and MARCH1 on the Received in revised form 13 February 2013 regulation of MHC II trafficking and TLR signaling. Our results show that MARCH1-deficient mice splenocytes Accepted 14 February 2013 are impaired in their capacity to produce pro-inflammatory cytokines in response to poly(I:C) and that TLR3 and MHC II molecules interact in the endocytic pathway.
    [Show full text]